Roche touts 2-year Evrysdi data as oral SMA drug drives early interest aliu Mon, 09/28/2020 – 08:42

GlaxoSmithKline’s Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease kblankenship Mon, 09/28/2020 – […]

Medications often have unwanted side-effects. One reason is that they reach not only the unhealthy cells for which […]

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect […]

Questions remain as to the practicality of lifting the cap on medical school places from the current 9500 […]

We have serious concerns about health promotion after the recent announcement that Public Health England will be disbanded.12 […]

A GP turned climate change activist who spent four weeks in prison on remand after being charged with […]

Drug is being investigated in up to 800 hospitalised patients nationwide

Treatment is indicated for use in adults with moderate-to-severe active rheumatoid arthritis

Pharma industry bodies call for medicine supply to be safeguarded in upcoming talks